UPDATE: Barrington Research Reiterates its Outperform Rating of Dolby Laboratories
In a report issued Friday, Barrington Research reiterated its Outperform rating of Dolby Laboratories (NYSE: DLB) while lowering their price target from $50.00 down to $42.00.
Barrington Research went on to say that "Management pointed to progress in broadcasting and mobile devices. However, weakness in consumer electronics products, including DVD and Blu-ray, is posing a drag. In addition, 3D remains a weak area, although the combined cinema efforts involving audio, video and 3D collectively remain an important effort."
Dolby Laboratories traded around $35 Friday
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.